Replay: Corporate Access: Conversations with the C-Suite 2026 – EU Healthcare – Roche (ROG.S)

Research evidence excerpt

Replay: Corporate Access: Conversations with the C-Suite 2026 – EU Healthcare – Roche (ROG.S)

Equity Research

27 May 2026

Replay: Corporate Access

Conversations with the C-Suite

2026 – EU Healthcare – Roche

(ROG.S) European Pharmaceuticals,

Biotechnology & Life Sciences

Roche CEO expressed confidence in 1) breast cancer (gire James Gordon

approval in Oct, >$11bn peak), 2) multiple sclerosis +44 (0)20 7116 2784

james.gordon@barclays.com

(comfortable on fene safety, >$4bn peak), 3) obesity Barclays, UK

(GLP1/GIP P2 at ADA, filing by '28), 4) broader pipeline (19 Yihan Li, PhD

NME readouts by '30), 5) margins, and 6) ROP's AI +44 (0)20 3555 3563 yihan.li@barclays.com

differentiation. Barclays, UK

Shirley Chen, PhD

+44 (0)20 7773 2109

Please see below replay information for the event held on shirley.chen@barclays.com

Thursday, 21 May 2026 at 1:30pm – 2:30pm UTC Barclays, UK

Sidhartha Modi

This replay is strictly and solely for the benefit of the intended recipients. Barclays Events Terms of +91 (0)22 6175 1326

Service and the Barclays Events Privacy Notice sidhartha.modi@barclays.com

Barclays, UK

Watch Charles Pitman-King, CFA +44 (0)20 3134 6023

charles.pitman-king@barclays.com

This transcript/recording is provided in an unedited format. Barclays is not responsible for the Barclays, UK

recording quality or any transcription errors or omissions.

Appearances by Third-Party Speakers: Any views or opinions expressed by third-party speakers

during this event are solely those of the speaker and do not represent the views or opinions of

Barclays. Barclays is not responsible for, and makes no warranties whatsoever as to, the

information or opinions contained in any written, electronic, audio or video presentations by any

third-party speakers at the event (“Third-Party Content”).